370 related articles for article (PubMed ID: 31439353)
1. Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques.
Egaña-Gorroño L; Chinnasamy P; Casimiro I; Almonte VM; Parikh D; Oliveira-Paula GH; Jayakumar S; Law C; Riascos-Bernal DF; Sibinga NES
Atherosclerosis; 2019 Oct; 289():184-194. PubMed ID: 31439353
[TBL] [Abstract][Full Text] [Related]
2. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
3. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis.
Tao H; Yancey PG; Babaev VR; Blakemore JL; Zhang Y; Ding L; Fazio S; Linton MF
J Lipid Res; 2015 Aug; 56(8):1449-60. PubMed ID: 26059978
[TBL] [Abstract][Full Text] [Related]
4. Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.
Seneviratne AN; Edsfeldt A; Cole JE; Kassiteridi C; Swart M; Park I; Green P; Khoyratty T; Saliba D; Goddard ME; Sansom SN; Goncalves I; Krams R; Udalova IA; Monaco C
Circulation; 2017 Sep; 136(12):1140-1154. PubMed ID: 28698173
[TBL] [Abstract][Full Text] [Related]
5. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
[TBL] [Abstract][Full Text] [Related]
6.
Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
[TBL] [Abstract][Full Text] [Related]
7. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.
Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W
Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215
[TBL] [Abstract][Full Text] [Related]
8. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
Yu P; Qian AS; Chathely KM; Trigatti BL
Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis.
Fan X; Han J; Zhong L; Zheng W; Shao R; Zhang Y; Shi S; Lin S; Huang Z; Huang W; Cai X; Ye B
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1365-1378. PubMed ID: 38695170
[TBL] [Abstract][Full Text] [Related]
10. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
[TBL] [Abstract][Full Text] [Related]
11. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
13. CD70 limits atherosclerosis and promotes macrophage function.
Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
15. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
16. Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses.
da Silva RL; Elizondo DM; Brandy NZD; Haddock NL; Boddie TA; de Oliveira LL; de Jesus AR; de Almeida RP; de Moura TR; Lipscomb MW
Sci Rep; 2021 Jan; 11(1):946. PubMed ID: 33441583
[TBL] [Abstract][Full Text] [Related]
17. CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis.
Lv JJ; Wang H; Zhang C; Zhang TJ; Wei HL; Liu ZK; Ma YH; Yang Z; He Q; Wang LJ; Duan LL; Chen ZN; Bian H
Circ Res; 2024 Jan; 134(2):165-185. PubMed ID: 38166463
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-specific deletion of MIC26 (APOO) mitigates advanced atherosclerosis by increasing efferocytosis.
Tang X; Huang Z; Wang F; Chen J; Qin D; Peng D; Yu B
Atherosclerosis; 2023 Dec; 386():117374. PubMed ID: 37995600
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
Song D; Fang G; Mao SZ; Ye X; Liu G; Miller EJ; Greenberg H; Liu SF
Atherosclerosis; 2018 Mar; 270():68-75. PubMed ID: 29407890
[TBL] [Abstract][Full Text] [Related]
20. The role of macrophage transcription factor MafB in atherosclerotic plaque stability.
Hasegawa H; Watanabe T; Kato S; Toshima T; Yokoyama M; Aida Y; Nishiwaki M; Kadowaki S; Narumi T; Honda Y; Otaki Y; Honda S; Shunsuke N; Funayama A; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Abe S; Shibata Y; Kubota I
Atherosclerosis; 2016 Jul; 250():133-43. PubMed ID: 27214395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]